宜安科技(300328.SZ)漲近7% 純鎂醫用鎂骨釘屬全球首創
格隆匯12月4日丨宜安科技(300328.SZ)漲6.84%,報13.28元,暫成交2.41億元,最新總市值61.13億元。
宜安科技12月2日盤後在深交所互動易平台表示,從適應症方面來講,公司的醫用鎂骨釘是全球首創。公司的醫用鎂骨釘是純鎂,德國和韓國的是鎂合金。與國際鎂合金產品相比,公司純鎂螺釘組成元素單一,不需要考慮其他金屬元素的毒性,生物安全性方面更具優勢。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.